Frankfurt - Delayed Quote EUR

Teleflex Incorporated (TBH.F)

Compare
174.00
+2.00
+(1.16%)
As of 9:07:15 AM GMT+1. Market Open.
Loading Chart for TBH.F
DELL
  • Previous Close 172.00
  • Open 174.00
  • Bid 173.00 x 10000
  • Ask 178.00 x 10000
  • Day's Range 174.00 - 174.00
  • 52 Week Range 164.00 - 234.00
  • Volume 10
  • Avg. Volume 0
  • Market Cap (intraday) 8.081B
  • Beta (5Y Monthly) 1.18
  • PE Ratio (TTM) 35.51
  • EPS (TTM) 4.90
  • Earnings Date Feb 20, 2025 - Feb 24, 2025
  • Forward Dividend & Yield 1.29 (0.75%)
  • Ex-Dividend Date Nov 15, 2024
  • 1y Target Est --

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

www.teleflex.com

14,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TBH.F

View More

Performance Overview: TBH.F

Trailing total returns as of 1/6/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

TBH.F
2.35%
S&P 500
0.60%

1-Year Return

TBH.F
19.62%
S&P 500
26.51%

3-Year Return

TBH.F
39.68%
S&P 500
26.42%

5-Year Return

TBH.F
46.76%
S&P 500
83.70%

Compare To: TBH.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TBH.F

View More

Valuation Measures

As of 1/3/2025
  • Market Cap

    8.22B

  • Enterprise Value

    9.80B

  • Trailing P/E

    35.04

  • Forward P/E

    11.21

  • PEG Ratio (5yr expected)

    0.90

  • Price/Sales (ttm)

    2.76

  • Price/Book (mrq)

    1.83

  • Enterprise Value/Revenue

    3.32

  • Enterprise Value/EBITDA

    16.23

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.85%

  • Return on Assets (ttm)

    3.15%

  • Return on Equity (ttm)

    5.41%

  • Revenue (ttm)

    3.03B

  • Net Income Avi to Common (ttm)

    238.01M

  • Diluted EPS (ttm)

    4.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    258.94M

  • Total Debt/Equity (mrq)

    42.67%

  • Levered Free Cash Flow (ttm)

    292.79M

Research Analysis: TBH.F

View More

People Also Watch